1. Home
  2. FGEN vs SWIN Comparison

FGEN vs SWIN Comparison

Compare FGEN & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • SWIN
  • Stock Information
  • Founded
  • FGEN 1993
  • SWIN 2017
  • Country
  • FGEN United States
  • SWIN Hong Kong
  • Employees
  • FGEN N/A
  • SWIN N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • SWIN
  • Sector
  • FGEN Health Care
  • SWIN
  • Exchange
  • FGEN Nasdaq
  • SWIN Nasdaq
  • Market Cap
  • FGEN 33.5M
  • SWIN 32.1M
  • IPO Year
  • FGEN 2014
  • SWIN 2023
  • Fundamental
  • Price
  • FGEN $5.61
  • SWIN $3.88
  • Analyst Decision
  • FGEN Strong Buy
  • SWIN
  • Analyst Count
  • FGEN 1
  • SWIN 0
  • Target Price
  • FGEN $250.00
  • SWIN N/A
  • AVG Volume (30 Days)
  • FGEN 60.2K
  • SWIN 275.0K
  • Earning Date
  • FGEN 08-05-2025
  • SWIN 08-21-2025
  • Dividend Yield
  • FGEN N/A
  • SWIN N/A
  • EPS Growth
  • FGEN N/A
  • SWIN N/A
  • EPS
  • FGEN N/A
  • SWIN N/A
  • Revenue
  • FGEN $6,996,000.00
  • SWIN $3,316,000.00
  • Revenue This Year
  • FGEN N/A
  • SWIN $29.79
  • Revenue Next Year
  • FGEN N/A
  • SWIN $54.60
  • P/E Ratio
  • FGEN N/A
  • SWIN N/A
  • Revenue Growth
  • FGEN N/A
  • SWIN N/A
  • 52 Week Low
  • FGEN $4.50
  • SWIN $1.16
  • 52 Week High
  • FGEN $38.25
  • SWIN $3.92
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 39.07
  • SWIN 86.60
  • Support Level
  • FGEN $4.85
  • SWIN $2.88
  • Resistance Level
  • FGEN $5.77
  • SWIN $3.48
  • Average True Range (ATR)
  • FGEN 0.57
  • SWIN 0.35
  • MACD
  • FGEN -0.02
  • SWIN 0.15
  • Stochastic Oscillator
  • FGEN 31.67
  • SWIN 96.08

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About SWIN Solowin Holdings

Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.

Share on Social Networks: